黑料网

Exosomes; Intercellular Communication; Immune Regulation; Biogenesis; Composition; Therapeutic Potential

Introduction

Cell-to-cell communication is essential for coordinating diverse biological processes, including development, homeostasis, and immune responses [1]. While direct cell-cell contact and soluble factors have long been recognized as primary modes of communication, recent studies have uncovered the crucial role of extracellular vesicles, particularly exosomes, in intercellular signaling. Exosomes are small membrane-bound vesicles (30-150 nm) released by various cell types into the extracellular environment [2]. They carry a cargo of bioactive molecules, including proteins, nucleic acids, and lipids, which can be transferred to recipient cells, thereby influencing their function and phenotype.

Biogenesis and composition of exosomes

Exosomes originate from the endosomal pathway, where intraluminal vesicles (ILVs) are formed within multivesicular bodies (MVBs). The fusion of MVBs with the plasma membrane results in the release of exosomes into the extracellular space [3]. Exosomes contain a diverse array of molecules derived from their parent cells, reflecting their cellular origin and physiological state. Proteomic, lipidomic, and nucleic acid analyses have revealed the presence of specific markers, such as tetraspanins (CD9, CD63, CD81), heat shock proteins (HSP70, HSP90), and various RNA species (mRNA, microRNA, long noncoding RNA), which contribute to their unique composition and functional diversity [4].

Intercellular communication via exosomes

Exosomes serve as carriers of intercellular communication by delivering their cargo to recipient cells through various mechanisms, including endocytosis, membrane fusion, and receptor-ligand interactions. Once internalized, exosomal molecules can modulate the signaling pathways and gene expression profiles of recipient cells, thereby influencing their behavior and phenotype [5]. In the context of immune regulation, exosomes derived from immune cells, such as dendritic cells, macrophages, and T cells, play critical roles in orchestrating immune responses by promoting antigen presentation, activating or suppressing immune cells, and modulating inflammatory signaling pathways.

Role of exosomes in immune regulation

Exosomes exert diverse effects on immune cells, contributing to the regulation of both innate and adaptive immune responses. Dendritic cell-derived exosomes, for example, facilitate antigen presentation to T cells, thereby initiating and shaping adaptive immune responses [6]. Tumor-derived exosomes, on the other hand, can suppress immune surveillance and promote immune evasion by inducing T cell dysfunction and polarization of macrophages towards a pro-tumorigenic phenotype. Additionally, exosomes released during inflammation can amplify immune responses by transferring inflammatory mediators, such as cytokines and chemokines, to neighboring cells.

Therapeutic potential of exosomes in immune-related disorders

The unique properties of exosomes, including their biocompatibility, stability, and ability to traverse biological barriers, make them attractive candidates for therapeutic applications in immune-related disorders. Strategies involving the modification of exosomal cargo, engineering of exosome-producing cells, and targeted delivery of exosomes to specific cell types hold promise for the development of novel therapeutic interventions [7]. Clinical studies investigating the use of exosomebased therapies for immune modulation, tissue regeneration, and immunotherapy are currently underway, underscoring the translational potential of exosome research in clinical settings.

Future perspectives

Despite significant progress in understanding the roles of exosomes in intercellular communication and immune regulation, several challenges and unanswered questions remain. Elucidating the mechanisms governing exosome biogenesis, cargo sorting, and uptake by recipient cells will provide valuable insights into their physiological functions and therapeutic potential [8]. Moreover, further exploration of exosome-based therapies in preclinical models and clinical trials is warranted to fully harness their therapeutic benefits and address potential safety concerns. Continued interdisciplinary efforts combining expertise in cell biology, immunology, and nanotechnology will drive the development of innovative exosome-based strategies for treating immune-related disorders and advancing personalized medicine.

Conclusion

In conclusion, exosomes represent versatile mediators of intercellular communication and immune regulation, with implications for various physiological and pathological processes. Their ability to transfer bioactive molecules between cells makes them attractive candidates for therapeutic intervention in immune-related disorders. By elucidating the mechanisms underlying exosomemediated signaling and harnessing their therapeutic potential, we can pave the way for the development of novel diagnostic tools and targeted therapies for immune-related diseases.

References

1. Aronson JK (2017)Br J Clin Pharmacol 83: 8-19.

, ,

2. Morovic W, Budinoff CR (2021). Trends Microbiol 29: 117-126.

, ,

3. Fernández DJ, Lamkanfi M (2015)Biol Chem 396: 193-203.

, ,

4. Alenghat T, Osborne LC, Saenz SA, Kobuley D, Ziegler CG, et al. (2013)Nature 504: 153-157.

, ,

5. Avila M, Ojcius DM, Yilmaz O (2009)DNA Cell Biol 28: 405-411.

, ,

6. Belkaid Y, Naik S (2013). Nature immunology 14: 646-653.

, ,

7. Blainey PC, Milla CE, Cornfield DN, Quake SR (2012)Sci Transl Med 4: 153-130.

, ,

8. Chieppa M, Rescigno M, Huang AY, Germain RN (2006)The Journal of experimental medicine 203: 2841-2852.

, ,